With the lifting of sanctions, many announced their readiness to work with “Actoverco

Author:
Actoverco
Date:
19 January 2016
nahaleh naraghi ceo of actoverco

We have a program for production of Rituximab and Bevacizumab drugs for cancer patients, ophthalmologists, etc. These drugs are very expensive due to their high technical knowledge, and from next year, we will also produce the raw materials for these drugs ourselves.

We have a program for production of Rituximab and Bevacizumab drugs for cancer patients, ophthalmologists, etc. These drugs are very expensive due to their high technical knowledge, and from next year, we will also produce the raw materials for these drugs ourselves.

Dr. Mostofi, the CEO of factory, during the visit of the German economic delegation as one of the most reputable pharmaceutical companies in the country, said: “Actoverco is the official representative of 6 world-class pharmaceutical companies and during 40 years these companies trusted Actoverco to enter the dynamic market of Iran. Said a nationwide drug.”

According to the public relations of Actover Group, Dr. Reza Mostofi, in an interview with reporters, by referring to the activities of Actoverco Company, stated: “Currently, we have a wide range of drugs in our company’s product portfolio. At first, we started our work with the production of oral drugs and moved on toward the production of injectable drugs. Accordingly, the production of biological drugs has been on the company’s agenda.

Related Links :

rituxiver

Actoverco presentation

 

Related Posts

actover news-min

Actoverco launches diabetes drug “Trytis”

labour day

“International Labour Day”

فوتسال-min

Actoverco host a Futsal tournament!

a letter from nahaleh naraghi

Bright future for pharmaceutical industry in Iran!

national health week actoverco

Message from Ms. Nahaleh Naraqi on the occasion of Health Week